Beranda › Glioblastoma › Texas › Houston
Uji klinis Glioblastoma di Houston, TX
25 studi untuk Glioblastoma mencari peserta di lokasi sekitar Houston (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Menerima pesertaFase 2/3
- University of Texas - MD Anderson Cancer Center, Houston
GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
Menerima pesertaFase 1
- Baylor St. Luke's Medical Center, Houston
A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
Menerima pesertaFase 1
- MD Anderson Cancer Center, Houston
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Menerima pesertaFase 1/2
- Baylor College of Medicine, Houston
MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
Menerima pesertaFase 1
- M D Anderson Cancer Center, Houston
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
Menerima pesertaFase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Anti-GD2 ADC M3554 in Advanced Solid Tumors
Menerima pesertaFase 1
- The University of Texas MD Anderson Cancer Center, Houston
Targeted Pediatric High-Grade Glioma Therapy
Menerima pesertaStudi observasional
- Texas Children's Hospital, Houston
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Menerima pesertaFase 1
- MD Anderson Cancer Center, Houston
Study of Olutasidenib and Temozolomide in HGG
Menerima pesertaFase 2
- Texas Children's Hospital, Houston
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Menerima pesertaFase 3
- MD Anderson Cancer Center, Houston
A Phase1 Clinical Trial Evaluating Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1 In Recurrent Glioblastoma
Menerima pesertaFase 1
- MD Anderson Cancer Center, Houston
Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)
Menerima pesertaFase 1
- Excel Diagnostics & Nuclear Oncology Center, Houston
A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma
Menerima pesertaFase 1/2
- The University of Texas M. D. Anderson Cancer Center, Houston
- The University of Texas MD Anderson Cancer Center, Houston
Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
Menerima pesertaSukarelawan sehat diterima
- M D Anderson Cancer Center, Houston
Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas
Menerima pesertaFase 2
- M D Anderson Cancer Center, Houston
DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
Menerima pesertaFase 2
- UTHealth Houston, Houston
- Baylor College of Medicine, Houston
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Menerima pesertaFase awal 1Sukarelawan sehat diterima
- Texas Children's Hospital, Houston
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Menerima pesertaFase 2
- Texas Children's Hospital, Houston
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Menerima pesertaFase 1/2
- MD Anderson Cancer Center, Houston
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
Menerima pesertaFase 1/2
- Houston Methodist Neurological Institute, Houston
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Menerima pesertaFase 1/2
- Houston Methodist Neurological Institute, Houston
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Houston
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Menerima pesertaFase 1/2
- MD Anderson Cancer Center, Houston
Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
Menerima pesertaFase 1
- UT MD Anderson Cancer Center, Houston
Uji klinis Glioblastoma di kota lain
- New York City, NY30 studi
- Boston, MA28 studi
- Los Angeles, CA23 studi
- Durham, NC20 studi
- San Francisco, CA17 studi
- Washington, DC15 studi
- Chicago, IL15 studi
- Rochester, MN15 studi
- Columbus, OH14 studi
- Miami, FL14 studi
- Jacksonville, FL13 studi
- Aurora, CO12 studi
Studi lain di Houston
- Kanker Paru Non-Sel Kecil145 studi
- Kanker Payudara126 studi
- Kanker (semua jenis)121 studi
- Kanker Metastatik104 studi
- Kanker Kolorektal102 studi
- Kanker Ovarium89 studi
- Leukemia Mieloid Akut85 studi
- Kanker Paru78 studi
- Kanker Prostat76 studi
- Kanker Endometrium68 studi
- Kanker Pankreas61 studi
- Melanoma59 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.